ARTHRITIS RECHERCHE & DEVELOPPEMENT : revenue, balance sheet and financial ratios

ARTHRITIS RECHERCHE & DEVELOPPEMENT is a French company founded 12 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in NEUILLY-SUR-SEINE (92200), this company of category PME shows in 2024 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ARTHRITIS RECHERCHE & DEVELOPPEMENT (SIREN 799328794)
Indicator 2024 2022 2021 2020 2019 2018 2017 2016
Revenue 1 063 788 € 8 844 € 16 975 € 63 569 € 70 569 € 77 509 € 125 739 € 245 605 €
Net income 476 877 € 148 356 € -77 501 € 155 904 € -22 063 € -156 640 € 154 507 € -20 875 €
EBITDA 663 721 € -55 414 € 30 639 € 282 954 € 254 187 € 155 186 € 310 038 € 68 077 €
Net margin 44.8% 1677.5% -456.6% 245.3% -31.3% -202.1% 122.9% -8.5%

Revenue and income statement

In 2024, ARTHRITIS RECHERCHE & DEVELOPPEMENT achieves revenue of 1.1 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +20.1%. Vs 2022, growth of +11928% (9 k€ -> 1.1 M€). After deducting consumption (54 €), gross margin stands at 1.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 664 k€, representing 62.4% of revenue. Positive scissor effect: EBITDA margin improves by +689.0 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 477 k€, i.e. 44.8% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 063 788 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 063 734 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

663 721 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

186 284 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

476 877 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

61.1%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 51.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

13.524%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

10.853%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

51.374%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.537

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

9.8%

Solvency indicators evolution
ARTHRITIS RECHERCHE & DEVELOPPEMENT

Sector positioning

Debt ratio
13.52 2024
2021
2022
2024
Q1: 0.0
Med: 5.61
Q3: 47.03
Average -20 pts over 3 years

In 2024, the debt ratio of ARTHRITIS RECHERCHE & DEV... (13.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
10.85% 2024
2021
2022
2024
Q1: 6.21%
Med: 32.46%
Q3: 67.88%
Average -29 pts over 3 years

In 2024, the financial autonomy of ARTHRITIS RECHERCHE & DEV... (10.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
1.54 years 2024
2021
2022
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Average +50 pts over 3 years

In 2024, the repayment capacity of ARTHRITIS RECHERCHE & DEV... (1.54) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 516.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

516.305

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
ARTHRITIS RECHERCHE & DEVELOPPEMENT

Sector positioning

Liquidity ratio
516.3 2024
2021
2022
2024
Q1: 120.11
Med: 218.14
Q3: 571.7
Good +9 pts over 3 years

In 2024, the liquidity ratio of ARTHRITIS RECHERCHE & DEV... (516.30) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.0x 2024
2021
2022
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.61x
Average

In 2024, the interest coverage of ARTHRITIS RECHERCHE & DEV... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 127 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1383 days. Excellent situation: suppliers finance 1256 days of the operating cycle (retail model). Inventory turnover is 2 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 37 days of revenue, i.e. 111 k€ to permanently finance. Over 2016-2024, WCR increased by +51%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

110 645 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

127 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

1383 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

2 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

37 j

WCR and payment terms evolution
ARTHRITIS RECHERCHE & DEVELOPPEMENT

Positioning of ARTHRITIS RECHERCHE & DEVELOPPEMENT in its sector

Comparison with sector Autres activités de soutien aux entreprises n.c.a.

Valuation estimate

Based on 131 transactions of similar company sales (all years), the value of ARTHRITIS RECHERCHE & DEVELOPPEMENT is estimated at 2 039 458 € (range 634 710€ - 3 914 824€). With an EBITDA of 663 721€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
131 transactions
634k€ 2039k€ 3914k€
2 039 458 € Range: 634 710€ - 3 914 824€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
663 721 € × 4.8x
Estimation 3 218 921 €
966 555€ - 5 537 521€
Revenue Multiple 30%
1 063 788 € × 0.36x
Estimation 379 361 €
189 471€ - 717 060€
Net Income Multiple 20%
476 877 € × 3.3x
Estimation 1 580 947 €
472 956€ - 4 654 729€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres activités de soutien aux entreprises n.c.a.)

Compare ARTHRITIS RECHERCHE & DEVELOPPEMENT with other companies in the same sector:

Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.

Frequently asked questions about ARTHRITIS RECHERCHE & DEVELOPPEMENT

What is the revenue of ARTHRITIS RECHERCHE & DEVELOPPEMENT ?

The revenue of ARTHRITIS RECHERCHE & DEVELOPPEMENT in 2024 is 1.1 M€.

Is ARTHRITIS RECHERCHE & DEVELOPPEMENT profitable?

Yes, ARTHRITIS RECHERCHE & DEVELOPPEMENT generated a net profit of 477 k€ in 2024.

Where is the headquarters of ARTHRITIS RECHERCHE & DEVELOPPEMENT ?

The headquarters of ARTHRITIS RECHERCHE & DEVELOPPEMENT is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.

Where to find the tax return of ARTHRITIS RECHERCHE & DEVELOPPEMENT ?

The tax return of ARTHRITIS RECHERCHE & DEVELOPPEMENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ARTHRITIS RECHERCHE & DEVELOPPEMENT operate?

ARTHRITIS RECHERCHE & DEVELOPPEMENT operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.